GlassScriptPhysician profile
Samuel Szomstein
NPI 1861455578
$240,408.77
in general payments reported to CMS, 2019-2025
10 companies · $113K in 2025
The $113K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $17K · 2021: $6,408 · 2022: $5,857 · 2023: $897 · 2024: $83K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $141K · Education: $37K · Consulting Fee: $8,641 · Travel and Lodging: $7,150 · Food and Beverage: $3,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $140,860.00 |
| Education | $37,097.46 |
| Consulting Fee | $8,640.50 |
| Travel and Lodging | $7,149.63 |
| Food and Beverage | $3,219.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $136,630.02 | 2024-2025 | Zepbound, Taltz |
| Intuitive Surgical, INC. | $44,053.18 | 2022-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $25,842.65 | 2021-2025 | Maxtack, Signia, Truclear |
| Covidien LP | $21,520.41 | 2019-2020 | |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | $9,278.00 | 2019 | |
| Trevena, INC. | $2,500.00 | 2021 | |
| Medical Device Business Services, INC. | $284.60 | 2019 | |
| Davol INC. | $183.03 | 2025 | Phasix Mesh |
| Novo Nordisk INC | $93.78 | 2019 | |
| Abbvie INC. | $23.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Szomstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.